Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SHP099 (SHP099 free base) free base is an effective, selective, orally bioavailable, and efficacious SHP2 inhibitor (IC50 =0.07 μM and p-ERK modulation in cells IC50 = 0.250 μM). SHP099 shows dose-dependent pathway inhibition and antitumor activity in xenograft models.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 31.00 | |
2 mg | In stock | $ 44.00 | |
5 mg | In stock | $ 72.00 | |
10 mg | In stock | $ 101.00 | |
25 mg | In stock | $ 177.00 | |
50 mg | In stock | $ 237.00 | |
100 mg | In stock | $ 431.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 55.00 |
Description | SHP099 (SHP099 free base) free base is an effective, selective, orally bioavailable, and efficacious SHP2 inhibitor (IC50 =0.07 μM and p-ERK modulation in cells IC50 = 0.250 μM). SHP099 shows dose-dependent pathway inhibition and antitumor activity in xenograft models. |
Targets&IC50 | SHP2:0.07 μM, p-ERK:0.250 μM |
Synonyms | SHP099 free base, SHP 099, SHP-099 |
Molecular Weight | 352.26 |
Formula | C16H19Cl2N5 |
CAS No. | 1801747-42-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 5.5 mg/mL (15.61 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SHP099 1801747-42-1 Apoptosis Metabolism PERK Phosphatase inhibit SHP099 free base SHP 099 Inhibitor SHP-099 inhibitor